miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells.

Spizzo, R; Nicoloso, M S; Lupini, L; Lu, Y; Fogarty, J; Rossi, S; Zagatti, B; Fabbri, M; Veronese, A; Liu, X; Davuluri, R; Croce, C M; Mills, G; Negrini, M; Calin, G A

Spizzo, R; Nicoloso, M S; Lupini, L; Lu, Y; Fogarty, J; Rossi, S; Zagatti, B; Fabbri, M; Veronese, A; Liu, X; Davuluri, R; Croce, C M; Mills, G; Negrini, M; Calin, G A.

Affiliation

Spizzo R; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Cell Death Differ ; 17(2): 246-54, 2010 Feb.

Article in En | MEDLINE | ID: mdl-19730444

Subject(s)

Apoptosis/genetics; Breast Neoplasms/genetics; Estrogen Receptor alpha/metabolism; MicroRNAs/metabolism; Tumor Suppressor Protein p53/metabolism; Breast Neoplasms/pathology; Cell Division/genetics; Cell Line, Tumor; Cell Survival/genetics; Cyclin D1/metabolism; Estrogen Receptor alpha/genetics; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs/genetics; Transfection; Tumor Suppressor Protein p53/genetics

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Tumor Suppressor Protein p53 / Apoptosis / MicroRNAs / Estrogen Receptor alpha Limits: Female / Humans Language: En Journal: Cell Death Differ Year: 2010 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google